Ontology highlight
ABSTRACT: Background
Targeted pharmacotherapy has been increasingly applied in cancer treatment due to its breakthroughs. However, the unmet needs of cancer patients are still significant, highlighting the urgency to investigate patient preferences. It is unclear how patients deliberate their choices between different aspects of targeted therapy, including cost, efficacy, and adverse events. Since discrete choice experiments (DCEs) have been widely applied to patient preference elicitation, we reviewed DCEs on targeted therapy for different cancers. We also synthesized evidence on the factors influencing patients' choices and their willingness-to-pay (WTP) for survival when treated by targeted therapy.Methods
We searched databases, including PubMed, EMBASE and MEDLINE, up to August 1
SUBMITTER: Jiang S
PROVIDER: S-EPMC9813042 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature